BJ vs REGN · P/E 21, rev $20.50B vs P/E 14, rev $14.34B
BJs Wholesale Club Holdings Inc (BJ) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
BJs Wholesale Club Holdings Inc (BJ) is a discount stores company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BJ revenue for 2025-02-01 was $20.50B. Net income was $534.4M. Revenue was up 2.7% from 2024-02-03 to 2025-02-01. BJ currently screens at market cap $11.39B and trailing P/E 20.5.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BJ currently screens at market cap $11.39B and trailing P/E 20.5. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BJ and REGN stock pages for the full models.
Not investment advice.